Does DACARBAZINE Cause Basal cell carcinoma? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Basal cell carcinoma have been filed in association with DACARBAZINE (Dacarbazine). This represents 0.1% of all adverse event reports for DACARBAZINE.
6
Reports of Basal cell carcinoma with DACARBAZINE
0.1%
of all DACARBAZINE reports
1
Deaths
0
Hospitalizations
How Dangerous Is Basal cell carcinoma From DACARBAZINE?
Of the 6 reports, 1 (16.7%) resulted in death.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACARBAZINE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does DACARBAZINE Cause?
Febrile neutropenia (501)
Off label use (471)
Neutropenia (400)
Drug ineffective (261)
Pyrexia (245)
Neuropathy peripheral (239)
Product use in unapproved indication (219)
Disease progression (204)
Nausea (203)
Anaemia (186)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which DACARBAZINE Alternatives Have Lower Basal cell carcinoma Risk?
DACARBAZINE vs DACLATASVIR
DACARBAZINE vs DACLIZUMAB
DACARBAZINE vs DACOMITINIB
DACARBAZINE vs DACTINOMYCIN
DACARBAZINE vs DALBAVANCIN